These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34603182)

  • 21. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Task-specific oromandibular dystonia secondary to chewing Khat (Catha edulis)- A series of 35 cases.
    Wadia PM; Mathur V; Kukkle PL; Khanna JN
    Parkinsonism Relat Disord; 2023 Sep; 114():105806. PubMed ID: 37619301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oromandibular dystonia involving the lateral pterygoid muscles: four cases with different complexity.
    Møller E; Bakke M; Dalager T; Werdelin LM
    Mov Disord; 2007 Apr; 22(6):785-90. PubMed ID: 17290453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and treatment of cervical and oromandibular dystonia in acutely brain-injured patients.
    Lo SE; Rosengart AJ; Novakovic RL; Kang UJ; Shah DN; Khan MA; Dalvi A; Goldenberg FD; Macdonald RL; Frank JI
    Neurocrit Care; 2005; 3(2):139-45. PubMed ID: 16174883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oromandibular dystonia and temporomandibular disorders.
    Handa S; Shaefer JR; Keith DA
    J Am Dent Assoc; 2022 Sep; 153(9):899-906. PubMed ID: 34863506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiological mechanisms of oromandibular dystonia.
    Manzo N; Ginatempo F; Belvisi D; Defazio G; Conte A; Deriu F; Berardelli A
    Clin Neurophysiol; 2022 Feb; 134():73-80. PubMed ID: 34979293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.
    Nastasi L; Mostile G; Nicoletti A; Zappia M; Reggio E; Catania S
    J Neurol; 2016 Sep; 263(9):1702-8. PubMed ID: 27278063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum toxin treatment of patients with oromandibular dystonia].
    Erdal J; Werdelin LM; Prytz S; Fuglsang-Frederiksen A; Møller E
    Ugeskr Laeger; 2000 Nov; 162(48):6567-71. PubMed ID: 11187229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.
    Bhattacharyya N; Tarsy D
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oromandibular dystonia: a dental approach.
    Maestre-Ferrín L; Burguera JA; Peñarrocha-Diago M; Peñarrocha-Diago M
    Med Oral Patol Oral Cir Bucal; 2010 Jan; 15(1):e25-7. PubMed ID: 19680172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia.
    Scorr LM; Silver MR; Hanfelt J; Sperin E; Freeman A; Jinnah HA; Factor SA
    Neurotherapeutics; 2018 Apr; 15(2):452-458. PubMed ID: 29542022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oromandibular Dystonia in Wilson's Disease.
    Kalita J; Ranjan A; Misra UK
    Mov Disord Clin Pract; 2015 Sep; 2(3):253-259. PubMed ID: 30363463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and clinical characteristics of patients with oromandibular dystonia seen in the orofacial pain clinic: a retrospective study.
    Sude A; Nixdorf DR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Aug; 130(2):169-174. PubMed ID: 32540317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory Open Jaw Oromandibular Tardive Dystonia with a Sensory Trick, Treated with Botulinum Toxin: A Case Report.
    Shalash AS; Abushouk AI; Elsherbeny MY; Elrassas H; Kamel T
    Neurol India; 2019; 67(4):1110-1111. PubMed ID: 31512647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin injection for the treatment of oromandibular dystonia.
    Blitzer A; Brin MF; Greene PE; Fahn S
    Ann Otol Rhinol Laryngol; 1989 Feb; 98(2):93-7. PubMed ID: 2916831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporomandibular disorder-related characteristics and treatment outcomes in Oromandibular Dystonia patients in two different clinical settings: A cross-sectional study.
    Sude A; Matsumoto J; Kaimal S; Petersen A; Nixdorf DR
    J Oral Rehabil; 2021 May; 48(5):542-550. PubMed ID: 33682178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral appliances in the treatment of oromandibular dystonia: a systematic review.
    De Meyer M; Vereecke L; Bottenberg P; Jacquet W; Sims AB; Santens P
    Acta Neurol Belg; 2020 Aug; 120(4):831-836. PubMed ID: 32594465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oromandibular Dystonia as a Side Effect of Methotrexate.
    Oliveira D; Moura D; Azevedo S; Guimarães B; Toste S
    Cureus; 2023 Oct; 15(10):e47248. PubMed ID: 38022297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.